Feldman, D. R., Sheinfeld, J., Bajorin, D. F., Fischer, P., Turkula, S., Ishill, N., . . . Motzer, R. J. (5/21/2009 Supplement Part 1 of 2). Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts. Journal of Clinical Oncology, 27, 5027-5028.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Feldman, D R., et al. "Paclitaxel (T) Plus Ifosfamide (I) Followed by High-dose Carboplatin (C) and Etoposide (E) with Autologous Stem Cell Support for Patients (pts) with Previously Treated Germ Cell Tumors (GCT): TI-CE Results and Prognostic Factor Analysis in 107 Pts."
Journal of Clinical Oncology 27 (5/21/2009 Supplement Part 1 of 2): 5027-5028.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Feldman, D R., et al. "Paclitaxel (T) Plus Ifosfamide (I) Followed by High-dose Carboplatin (C) and Etoposide (E) with Autologous Stem Cell Support for Patients (pts) with Previously Treated Germ Cell Tumors (GCT): TI-CE Results and Prognostic Factor Analysis in 107 Pts."
Journal of Clinical Oncology, vol. 27, 5/21/2009 Supplement Part 1 of 2, pp. 5027-5028.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.